The University of Southampton
University of Southampton Institutional Repository

Treatment of resistant pemphigus vulgaris with an anti-CD20 monoclonal antibody (Rituximab)

Cooper, H.L., Healy, E., Theaker, J.M. and Friedmann, P.S. (2003) Treatment of resistant pemphigus vulgaris with an anti-CD20 monoclonal antibody (Rituximab) Clinical and Experimental Dermatology, 28, (4), pp. 366-368. (doi:10.1046/j.1365-2230.2003.01283.x).

Record type: Article


We describe a 54-year-old man with resistant pemphigus vulgaris. Standard therapies had afforded inadequate control and have been associated with considerable side-effects. The anti-CD20 monoclonal antibody, Rituximab (MabThera, Roche), was trialled with significant benefit. We discuss its potential mechanism of action.

Full text not available from this repository.

More information

Published date: July 2003


Local EPrints ID: 27003
ISSN: 0307-6938
PURE UUID: cf492800-318f-407d-ba2f-3ffc8e2210e6

Catalogue record

Date deposited: 26 Apr 2006
Last modified: 17 Jul 2017 16:05

Export record



Author: H.L. Cooper
Author: E. Healy
Author: J.M. Theaker
Author: P.S. Friedmann

University divisions

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton:

ePrints Soton supports OAI 2.0 with a base URL of

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.